Drug pricing and the 2024 presidential election
Fierce Pharma
OCTOBER 29, 2024
As the 2024 U.S. This week on "The Top Line," we explore how each presidential candidate’s approach to drug pricing could shape future policy.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Fierce Pharma
OCTOBER 29, 2024
As the 2024 U.S. This week on "The Top Line," we explore how each presidential candidate’s approach to drug pricing could shape future policy.
Fierce Pharma
OCTOBER 22, 2024
With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one. Following a string of high-profile deals, Samsung Biologics has locked down a $1.2 billion contract with an unnamed Asia-based pharmaceutical company that’s expected to run through December 2037.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 30, 2024
For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. |
Fierce Pharma
AUGUST 30, 2024
ESC 2024: UK's George Medicines posts positive results for triple-combo blood pressure drug on heels of FDA submission fkansteiner Fri, 08/30/2024 - 15:54
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
📆 November 21, 2024 at 11:00 AM PST, 2:00 PM EST, 7:00 PM GMT
Fierce Pharma
APRIL 1, 2024
The two most influential proxy advisory firms are rallying investors to vote against the 2024 pay proposal for Soriot at the company’s annual general meeting this month. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again.
Fierce Pharma
MARCH 27, 2024
WuXi Biologics stays the course with positive 2024 outlook as national security crackdown threatens business in US fkansteiner Wed, 03/27/2024 - 13:12
Fierce Pharma
DECEMBER 22, 2023
And it is with cautious optimism that industry watchers see the trend continuing in 2024. . | Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.
Pharmaceutical Technology
NOVEMBER 11, 2024
BostonGene is a winner in four categories in the 2024 Pharmaceutical Technology Excellence Awards.
David Bagga
MAY 29, 2024
How Much Do Medical Device Sales Reps Make in 2024? Home Blog How Much Do Medical Device Sales Reps Make in 2024? How Much Do Medical Device Sales Reps Make in 2024? It’s […] The post How Much Do Medical Device Sales Reps Make in 2024? appeared first on.
David Bagga
JULY 27, 2024
Medical Device Sales Academy How Much Do Medical Device Sales Reps Make in 2024? Currently, […] The post How Much Do Medical Device Sales Reps Make in 2024 appeared first on. When looking for a medical device sales rep job, a common question is, ‘How much does a medical device sales rep earn?
David Bagga
JULY 27, 2024
Medical Device Sales Academy How to Become A Medical Device Sales Rep in 2024? Here is a simple and brief […] The post How to Become A Medical Device Sales Rep in 2024? If you are considering a career in sales and healthcare, a position as a medical device sales representative may appeal to you. appeared first on.
Fierce Pharma
FEBRUARY 8, 2024
This week on “The Top Line,” we explore the most anticipated drug launches of 2024. This week on “The Top Line,” we explore the most anticipated drug launches of 2024.
Fierce Pharma
JANUARY 8, 2024
In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity. The late surge of activity in 2023 also bodes well for a 2024 uptick, the group said. Morgan Healthcare Conference. |
David Bagga
MAY 29, 2024
In 2018, the average base salary of a medical sales representative was $92,698 How to Become A Medical Device Sales Rep in 2024? Home Blog How to Become A Medical Device Sales Rep in 2024? How to Become A […] The post How to Become A Medical Device Sales Rep in 2024? appeared first on.
Fierce Pharma
AUGUST 5, 2024
Join us at Digital Pharma East 2024 on Sept. The pharmaceutical industry is in a constant state of evolution, driven by technological advancements, shifting consumer behaviors, and a complex regulatory landscape. 9-12 in Philadelphia to learn, connect, and innovate with your life sciences marketing industry peers.
MedCity News
OCTOBER 16, 2024
HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight the shifting landscape of healthcare innovation in many different settings. The post 12 Compelling Sessions to Check Out at HLTH 2024 appeared first on MedCity News. Register today!
David Bagga
JULY 27, 2024
Medical Device Sales Academy How to Become A Medical Sales Rep With No Experience 2024? Medical device sales representative salary […] The post How to Become A Medical Sales Rep With No Experience 2024? Medical device sales representative salary […] The post How to Become A Medical Sales Rep With No Experience 2024?
David Bagga
MAY 29, 2024
In 2018, the average base salary of a medical sales representative was $92,698 How to Become A Medical Sales Rep With No Experience 2024? Home Blog How to Become A Medical Sales Rep With No Experience 2024? How to […] The post How to Become A Medical Sales Rep With No Experience 2024? appeared first on.
MedCity News
NOVEMBER 1, 2024
The post Heard at HLTH 2024 Part 2: Insights from Innovative Healthcare Executives appeared first on MedCity News. Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Pharmaceutical Technology
NOVEMBER 6, 2024
The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved following the interest rate cuts by the US Federal Reserve in September 2024.
Fierce Pharma
FEBRUARY 1, 2024
On both fronts, Sanofi expects to see dividends in 2024. . | As Sanofi strives to become a global immunology leader, it's also busy making the most of a crucial respiratory launch with partner AstraZeneca.
Fierce Pharma
JANUARY 4, 2024
In 2024, CDMOs can advance their priorities on three fronts, a group of experts said during a recent Evaluate webinar on the state of the industry. Even after the heady highs of the COVID-19 era, the contract development and manufacturing organization (CDMO) realm remains one of biopharma's buzziest fields.
Clarivate
JUNE 19, 2024
Today we announce the 2024 release of the annual Journal Citation Reports (JCR ), which marks the completion of a series of significant changes we’ve implemented in recent years. Find out more about the 2024 Journal Citation Reports here. This blog will take you through what to expect in the application.
Fierce Pharma
JANUARY 3, 2024
Expect more of the same in 2024, according to a report from Evaluate, which places Novo and Lilly in the top two spots for global new sales.
Fierce Pharma
MAY 2, 2024
WuXi Biologics has withdrawn from the 2024 BIO International Convention as the U.S. . | Japan's Ono will buy kinase inhibitor expert Deciphera for $2.4 Novartis invests further in radiopharmaceuticals with two deals. grows hostile against certain Chinese biotech companies. And more.
PharmaTech
OCTOBER 3, 2024
Pharmaceutical Technology sat down with Erica Schlesinger, vice president of technical development at Serán Bioscience, to talk about her upcoming presentation at AAPS PharmSci 360 2024, “High Dose Subcutaneous Delivery of Protein Therapeutics.”
MedCity News
NOVEMBER 1, 2024
The post Heard at HLTH 2024: Insights from Innovative Healthcare Executives appeared first on MedCity News. Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
Pharmaceutical Technology
SEPTEMBER 26, 2024
West Pharmaceutical Services is a winner in the Safety category in the 2024 Pharmaceutical Technology Excellence Awards.
Referral MD
NOVEMBER 1, 2024
1, 2024 /PRNewswire-PRWeb/ — ReferralMD, a leader in healthcare technology solutions, announced today that it was recognized as a 2024 Top Company in Conversational AI upon the conclusion of extensive research and company outreach by AVIA Marketplace, the leading digital health marketplace. PLEASANT, S.C. , Nov.
MedCity News
SEPTEMBER 4, 2024
The post How Have Hospitals Fared Financially So Far in 2024? Health systems’ financial results suggest the start of sustained recovery, but persistent challenges remain, including rising expenses and less-than-ideal reimbursement rates from payers. appeared first on MedCity News.
Pharmaceutical Commerce
SEPTEMBER 3, 2024
Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar. In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G.
MedCity News
SEPTEMBER 11, 2024
HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine, retail health, women’s health, and lots more. The post Get Ready for HLTH 2024: A Preview Guide appeared first on MedCity News.
Zymewire
OCTOBER 15, 2024
In our Q3 2024 biopharma recap, we dive into the latest trends in funding, clinical trial activity, and therapeutic focus areas across the industry. With updated data on regional funding shifts and insights into the evolving biopharma landscape, this report will help CROs and CDMOs refine their strategies as they prepare for 2025.
European Pharmaceutical Review
DECEMBER 30, 2023
This activity is expected to continue in 2024, with increasing need for biopharma to access innovation through collaboration and dealmaking to offset looming patent challenges. “In Referencing the EY Firepower report 2023 , Baral highlights several key fundamentals that point to increased dealmaking in 2024.
PharmaTech
OCTOBER 11, 2024
Pharmaceutical Technology Europe spoke with John McQuaid, president and managing director at Almac Pharma Services, at CPHI Milan 2024, held October 8–10, in Milan, Italy, about how the pharmaceutical industry is growing and what might drive investment in the future.
pharmaphorum
JULY 31, 2024
GSK raises 2024 forecasts on a strong Q2 led by HIV and cancer drugs, but its shares weakened on litigation concerns and weaker vaccine expectations
Fierce Pharma
JANUARY 19, 2023
Bluebird extends cash runway to late 2024 with $113M raise through stock sale esagonowsky Thu, 01/19/2023 - 08:30
European Pharmaceutical Review
MARCH 5, 2024
International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. analytica 2024 provides a comprehensive overview of innovative analytics and molecular – as well as microbiological – testing methods. Top topics at the trade fair include digitalisation, Laboratory 4.0,
Pharmaceutical Technology
MARCH 11, 2024
Upcoming regulatory events for pipeline AAV gene therapies, with a focus on neuromuscular and blood disorders, are setting high expectations for the space in 2024.
PharmaTech
OCTOBER 10, 2024
Pharmaceutical Technology sat down with Niloufar Salehi, advisor at Eli Lilly & Company, to talk about the session she is moderating at AAPS PharmSci 360 2024, Symposium: An Accelerated Development of Poorly Soluble Drugs Using Predictive Tool.
MedCity News
JANUARY 30, 2024
A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.
European Pharmaceutical Review
JULY 1, 2024
CHMP meeting highlights: April 2024 The post CHMP meeting highlights – June 2024 appeared first on European Pharmaceutical Review. EMA’s human medicines committee decided to revoke the conditional marketing authorisation for Ocaliva. This medicine is intended for adults who have primary biliary cholangitis, a rare liver disease.
Fierce Pharma
JANUARY 9, 2023
JPM23: Bluebird touts gene therapy launch progress, extends cash runway to 2024. esagonowsky. Mon, 01/09/2023 - 09:26.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content